We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed
Dec 24
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedJan 06, 2026
DataAggregated Company Financials
Companies6
- 7D-2.2%
- 3M-19.4%
- 1Y-40.7%
- YTD1.7%
Over the last 7 days, the Pharma industry has dropped 3.5%, driven by InterCure declining 8.3%. On the other hand Tikun Olam-Cannbit Pharmaceuticals is actually up 25%. However, the industry is down 42% over the past year.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 06 Jan 2026 | ₪465.3m | ₪706.6m | -₪88,269,983.10 | 6.1x | -5.3x | 0.7x |
| Thu, 04 Dec 2025 | ₪529.0m | ₪706.6m | -₪93,414,260.70 | 6x | -5.7x | 0.7x |
| Sat, 01 Nov 2025 | ₪581.1m | ₪720.3m | -₪92,622,682.40 | 6.9x | -6.3x | 0.8x |
| Mon, 29 Sep 2025 | ₪547.6m | ₪716.6m | -₪84,451,466.30 | 6.8x | -6.5x | 0.8x |
| Wed, 27 Aug 2025 | ₪575.4m | ₪716.7m | -₪66,976,633.30 | 28.6x | -8.6x | 0.8x |
| Fri, 25 Jul 2025 | ₪563.0m | ₪716.7m | -₪71,542,381.10 | 29.1x | -7.9x | 0.8x |
| Sun, 22 Jun 2025 | ₪585.9m | ₪716.7m | -₪72,075,817.80 | 32.9x | -8.1x | 0.8x |
| Tue, 20 May 2025 | ₪579.1m | ₪732.8m | -₪81,732,372.00 | 14.9x | -7.1x | 0.8x |
| Thu, 17 Apr 2025 | ₪562.1m | ₪766.6m | -₪80,702,120.00 | 14.5x | -7x | 0.7x |
| Sat, 15 Mar 2025 | ₪651.2m | ₪828.6m | -₪164,975,244.00 | 21.1x | -3.9x | 0.8x |
| Mon, 10 Feb 2025 | ₪668.8m | ₪828.6m | -₪180,138,925.40 | 21.5x | -3.7x | 0.8x |
| Wed, 08 Jan 2025 | ₪680.8m | ₪828.6m | -₪181,090,218.20 | 20.7x | -3.8x | 0.8x |
| Fri, 06 Dec 2024 | ₪601.8m | ₪828.6m | -₪180,557,447.60 | 20.6x | -3.3x | 0.7x |
| Sun, 03 Nov 2024 | ₪684.7m | ₪808.7m | -₪205,489,888.80 | 22.9x | -3.3x | 0.8x |
| Tue, 01 Oct 2024 | ₪676.6m | ₪808.7m | -₪205,225,377.30 | 24.1x | -3.3x | 0.8x |
| Thu, 29 Aug 2024 | ₪693.7m | ₪900.7m | -₪252,196,073.90 | n/a | -2.8x | 0.8x |
| Sat, 27 Jul 2024 | ₪727.4m | ₪901.7m | -₪261,633,520.80 | n/a | -2.8x | 0.8x |
| Mon, 24 Jun 2024 | ₪644.5m | ₪901.7m | -₪258,177,438.00 | n/a | -2.5x | 0.7x |
| Wed, 22 May 2024 | ₪850.1m | ₪886.2m | -₪255,888,520.40 | n/a | -3.3x | 1x |
| Fri, 19 Apr 2024 | ₪734.6m | ₪956.4m | -₪181,379,552.00 | 20.3x | -4x | 0.8x |
| Sun, 17 Mar 2024 | ₪641.6m | ₪972.3m | -₪208,598,012.00 | 14.2x | -3.1x | 0.7x |
| Tue, 13 Feb 2024 | ₪627.4m | ₪972.3m | -₪212,473,607.50 | 13.2x | -3x | 0.6x |
| Thu, 11 Jan 2024 | ₪614.2m | ₪972.3m | -₪214,402,978.00 | 12.4x | -2.9x | 0.6x |
| Sat, 09 Dec 2023 | ₪614.7m | ₪972.3m | -₪213,522,545.00 | 10.7x | -2.9x | 0.6x |
| Mon, 06 Nov 2023 | ₪584.1m | ₪958.8m | -₪211,988,622.00 | 9x | -2.8x | 0.6x |
| Wed, 04 Oct 2023 | ₪690.5m | ₪958.8m | -₪210,439,393.00 | 13.3x | -3.3x | 0.7x |
| Fri, 01 Sep 2023 | ₪664.5m | ₪920.2m | -₪193,104,544.00 | 8.5x | -3.4x | 0.7x |
| Sun, 30 Jul 2023 | ₪643.2m | ₪918.8m | -₪126,340,660.00 | 8.5x | -5.1x | 0.7x |
| Tue, 27 Jun 2023 | ₪730.1m | ₪918.8m | -₪125,156,846.00 | 9.9x | -5.8x | 0.8x |
| Thu, 25 May 2023 | ₪817.3m | ₪906.2m | -₪127,468,980.00 | 11.7x | -6.4x | 0.9x |
| Sat, 22 Apr 2023 | ₪815.2m | ₪855.1m | -₪87,445,040.00 | 9.6x | -9.3x | 1x |
| Mon, 20 Mar 2023 | ₪752.5m | ₪815.6m | -₪72,373,894.00 | 12x | -10.4x | 0.9x |
| Wed, 15 Feb 2023 | ₪1.0b | ₪815.6m | -₪69,338,208.00 | 16.8x | -14.8x | 1.3x |
| Fri, 13 Jan 2023 | ₪1.0b | ₪739.7m | -₪55,528,113.00 | 17.3x | -18.3x | 1.4x |
Price to Earnings Ratio
-18.3x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.80x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 5.15% | |
| Healthcare | 2.36% | |
| Pharma | -2.17% | |
| Pharma | -2.17% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SEMG Seach Medical Group | ₪2.83 | 4.2% +₪3.8m | -9.9% | PE6.1x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪0.25 | 20.4% +₪3.6m | -36.2% | PS0.6x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪7.48 | 0.2% +₪65.6k | -8.8% | PB4.7x |
